Telehealth Depression Prescribing: What Psychiatrists Can Do in Michigan

You’re a psychiatrist or PMHNP considering telehealth, and you need a straight answer: Can I prescribe antidepressants and other depression medications remotely? What are the actual rules?

Short answer: Yes, psychiatrists can prescribe depression medications via telehealth in all 50 states (with proper state licensure). For PMHNPs, it depends on your state — some allow full independent prescribing, others require physician oversight.

The longer answer gets into the regulatory weeds that actually matter to your practice: state-by-state scope of practice differences, collaborative agreement requirements, telehealth parity laws that affect your reimbursement, and federal controlled substance rules for those anxiety/sleep adjuncts you might prescribe alongside SSRIs.

Here’s what you need to know to prescribe confidently (and legally) via telehealth in 2026.

Why Depression Treatment Works So Well in Telehealth

Depression medication management is arguably the easiest psychiatric specialty to deliver remotely. Here’s why:

Most antidepressants aren’t controlled substances. SSRIs, SNRIs, TCAs, atypical antidepressants — none of these trigger the federal Ryan Haight Act restrictions that apply to Schedule II-V medications. You can initiate an SSRI via video visit without the regulatory gymnastics required for Adderall or benzodiazepines.

Mental status exams translate to video. Unlike dermatology or orthopedics, you don’t need hands-on examination. You’re assessing mood, affect, thought process, and suicidality — all observable via secure video. The clinical standard of care is maintained.

Follow-up frequency actually improves. In traditional practice, asking a patient to drive 45 minutes for a 15-minute med check every two weeks feels excessive. Via telehealth, those critical early titration visits become realistic. Research shows telehealth improves medication adherence in depression treatment because check-ins are easier to schedule and attend.

E-prescribing to local pharmacies is seamless. Your patient in rural Texas can see you (licensed in Texas) via video, you send the prescription electronically to their neighborhood CVS, and they pick it up that afternoon. The infrastructure works.

Behavioral health telehealth visits remain more than 20 times higher than pre-pandemic levels, and mental health accounts for 35-45% of all telehealth visits nationally — it’s become the standard, not the exception.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What Psychiatrists Can Prescribe via Telehealth (Spoiler: Everything)

If you’re a board-certified psychiatrist (MD or DO), your prescribing authority via telehealth is essentially identical to in-person practice. State medical licensure grants full prescriptive authority; there are no diagnosis-specific or medication-class restrictions imposed by telehealth delivery.

For depression specifically, you can:

• Initiate first-line antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, etc.)
• Prescribe augmentation strategies (adding aripiprazole, lithium, thyroid hormone)
• Manage treatment-resistant cases (MAOIs, TCAs, esketamine coordination)
• Prescribe controlled substances when clinically indicated (benzodiazepines for comorbid anxiety, stimulants for ADHD/depression overlap, sleep aids)

That last point requires clarification. Federal controlled substance prescribing via telehealth was restricted pre-COVID (the Ryan Haight Act required an in-person exam before prescribing Schedule II-V medications). During the pandemic, the DEA waived this requirement.

As of 2026, temporary federal flexibilities remain in effect through at least December 31, 2025, with bipartisan support for extension or permanent rule-making. This means you can legally prescribe controlled medications via telehealth nationwide under current policy. The DEA and HHS are working on permanent telemedicine prescribing regulations expected by late 2025.

State licensure is your only hard limit. You must be licensed in the state where your patient is physically located during the telehealth visit. Want to treat patients across multiple states? You’ll need multi-state licensure. The Interstate Medical Licensure Compact (IMLC) streamlines this — 37 states participate, allowing expedited licensure across member states. A psychiatrist with 3-4 state licenses via the Compact can access a massive patient population via telehealth.

The Practical Workflow

A typical telehealth depression management workflow:

1. Initial psychiatric evaluation (60 min, CPT 90792 or E/M 99205) — comprehensive history, mental status exam, suicide risk assessment, diagnosis, treatment plan
2. Medication initiation — e-prescribe SSRI/SNRI to patient’s local pharmacy with dosing instructions
3. Close follow-up — video visits at 2 weeks, 4 weeks, 8 weeks to assess response, side effects, titrate dose (CPT 99213/99214 for 15-30 min med checks)
4. Maintenance phase — monthly or quarterly med management visits once stable

You can order labs when needed (thyroid function, metabolic panel before starting lithium, etc.) — the patient gets bloodwork locally and results route to you. You coordinate with therapists. You manage crises and safety planning. It’s comprehensive psychiatry, just delivered via HIPAA-compliant video platform instead of a physical office.

PMHNP Prescribing Authority: It Depends Where You Practice

Unlike psychiatrists, PMHNPs face state-specific scope of practice laws that determine whether you can prescribe independently or need physician oversight.

The American Association of Nurse Practitioners categorizes states into three groups:

• Full Practice Authority — NPs can evaluate, diagnose, and prescribe without physician supervision or collaborative agreements
• Reduced Practice Authority — NPs need collaborative agreements or physician involvement for certain aspects (often prescribing)
• Restricted Practice Authority — NPs must have continuous physician supervision/delegation for essentially all practice

As of 2026, 27 states plus DC have full practice authority for NPs. But several high-population states still impose restrictions, and psychiatric NPs sometimes face additional limitations beyond general NPs.

State-by-State Breakdown for Depression Prescribing

Here’s how prescribing authority shakes out in key states:

New York (Full Practice)

Since April 2022, New York allows experienced NPs (3,600+ clinical hours) to practice completely independently — no collaborative agreement required. A PMHNP in NY can evaluate patients, prescribe antidepressants and other psych medications, and manage depression cases without any physician involvement.

This puts PMHNPs essentially on par with psychiatrists for prescribing authority (though Medicare still reimburses NPs at 85% of the physician fee schedule). For telehealth platforms, recruiting PMHNPs in New York is straightforward — they function autonomously.

California (Transitioning to Full Practice)

California was historically one of the most restrictive states — NPs needed ‘standardized procedures’ co-signed by a supervising physician. AB 890 (passed 2020) is changing this in phases:

• Since January 2023: Experienced NPs meeting education/certification requirements can practice independently in group clinical settings (clinics, hospitals, healthcare facilities) without standardized procedures
• Beginning January 2026: Qualified NPs can obtain a special Board certification allowing fully independent practice in all settings, including private practice and telehealth platforms

A PMHNP in California who meets the criteria (typically master’s/doctorate, national certification, 3+ years supervised experience) can now prescribe depression medications independently. Those not yet certified still operate under the old restricted framework.

Bottom line for CA: The state is mid-transition. Many established PMHNPs already have independent authority; newer graduates or those outside qualifying settings still need physician oversight. By 2026, most practicing PMHNPs will have achieved independent status.

Pennsylvania (Reduced Practice)

Pennsylvania requires PMHNPs to maintain a collaborative agreement with a physician to prescribe. The physician doesn’t co-sign individual prescriptions, but the formal agreement must outline the NP’s scope, the physician’s availability for consultation, and periodic chart review requirements.

Recent legislation (Act 68 of 2021) created a pathway for experienced NPs to eventually obtain ‘independent prescriptive authority’ after a structured mentorship period, but as of 2026 Pennsylvania remains classified as Reduced Practice.

For depression care: A PMHNP in PA can absolutely manage depression patients and prescribe SSRIs, SNRIs, etc. — but they must have that collaborative agreement filed with the State Board. A psychiatrist supervising an NP doesn’t need to see the patients directly, but they’re legally responsible for oversight.

Telehealth platforms operating in PA need to arrange physician collaboration for their NP providers.

Illinois (Reduced Practice with FPA Pathway)

Illinois offers a middle ground. Standard NP practice requires a written collaborative agreement with a physician for prescribing. However, Illinois created a Full Practice Authority (FPA) license for experienced NPs who complete 4,000+ clinical hours under collaboration plus additional training.

PMHNPs with FPA status can practice and prescribe without ongoing collaborative agreements in most cases. One quirk: Illinois law requires NPs (even with FPA) to maintain a ‘consultation relationship’ with a physician when prescribing certain controlled substances like benzodiazepines or Schedule II medications. This isn’t daily supervision — more like having an MD available for clinical consultation on complex cases.

For depression treatment: FPA-licensed PMHNPs in Illinois can independently prescribe antidepressants. If the treatment plan involves adding a benzodiazepine for severe anxiety or a stimulant for comorbid ADHD, they’d need to document physician consultation (often a phone call or case review, not a formal co-signature).

Texas (Restricted Practice)

Texas maintains one of the strictest regulatory environments for NPs. All prescribing requires physician delegation via a Prescriptive Authority Agreement. The supervising physician must conduct regular chart reviews (specific percentages mandated by law) and periodic face-to-face meetings with the NP.

A 2023 bill (SB 1700, the ‘HEAL Texans Act’) proposed granting NPs full practice authority but failed to pass. As of 2026, Texas NPs — including psychiatric specialists — must have physician oversight.

For depression care: A PMHNP in Texas cannot prescribe antidepressants or any other medication without a delegating psychiatrist or physician. The collaboration must be formalized, documented, and maintained. Additionally, Texas generally prohibits NPs from prescribing Schedule II controlled substances in outpatient settings (hospital-based or hospice exceptions exist).

Given Texas’s severe psychiatrist shortage (only ~1 psychiatrist per 9,000 residents, ranking 43rd nationally), there’s enormous demand for mental health services. But the regulatory environment means telehealth platforms must either recruit MDs who can practice independently or create infrastructure for physician-NP collaborative teams.

Florida (Restricted Practice for Psych NPs)

Florida’s 2020 law created ‘autonomous practice’ for certain APRNs — but only for primary care NPs (family, pediatrics, internal medicine) and nurse midwives. Psychiatric NPs were explicitly excluded.

PMHNPs in Florida must practice under a written protocol with a supervising physician, including chart review and physician availability requirements. The supervising MD doesn’t need to be a psychiatrist but must be qualified to oversee psychiatric care.

For depression treatment: Florida PMHNPs can prescribe antidepressants and manage depression under their protocol. For controlled substances, Florida allows NP prescribing with some restrictions (e.g., Schedule II for acute pain limited to 7-day supply). PMHNPs can prescribe benzodiazepines or stimulants when clinically appropriate if their supervising physician delegates that authority in the protocol.

Florida has high demand (psychiatrist ratio ~1:8,500, ranking 42nd) but maintains restrictive practice laws. Psychiatrists have clear autonomy advantage here.

The Collaborative Agreement Reality

In reduced/restricted practice states, collaborative agreements aren’t just paperwork — they’re legal contracts defining the scope of NP practice. Typical requirements include:

• Physician review of X% of patient charts monthly (varies by state, often 5-20%)
• Availability for consultation (phone/email, not necessarily in-person)
• Periodic face-to-face meetings between NP and supervising MD (quarterly or annually)
• Defined protocols for medication categories, referral pathways, emergency situations
• Documentation of the relationship filed with state nursing board

For NPs considering telehealth: If you’re in a restricted state, confirm the platform has physician oversight infrastructure. You can’t just hang your own shingle without the collaborative relationship in place.

For psychiatrists: If you’re asked to supervise an NP, understand you’re assuming legal responsibility for oversight. The good news? It’s usually not hands-on daily management — you’re reviewing charts, being available for questions, and signing off that the NP is practicing within appropriate scope. Many psychiatrists find this arrangement expands their practice’s capacity while maintaining quality.

Reimbursement: Does Telehealth Pay the Same as In-Person?

One of the biggest provider concerns about telehealth: Will insurance actually pay me fairly for virtual visits, or am I taking a financial hit?

Thanks to telehealth parity laws, medication management visits are reimbursed at the same rates as in-person in most cases.

Telehealth Parity Laws by the Numbers

As of April 2025:

• 44 states plus DC mandate that private insurance cover telehealth services
• 23 states explicitly require payment parity — insurers must reimburse telehealth at the same rate as in-person care
• The federal Mental Health Parity and Addiction Equity Act reinforces equitable coverage for behavioral health services, including telehealth delivery

States like New York and Illinois have strong parity provisions (NY’s 2021 law requires telehealth ‘on the same basis and at the same rate’ as face-to-face; Illinois enacted permanent payment parity in 2021). California, Pennsylvania, Texas, and Florida all have telehealth coverage laws, though not all explicitly mandate equal payment — however, major insurers typically pay parity for mental health telehealth because it’s cost-effective and the services are in high demand.

What You’ll Actually Get Paid

Psychiatrists typically bill evaluation and management (E/M) codes for medication management visits:

• CPT 99213 (15-min established patient, low complexity): ~$80-100
• CPT 99214 (25-30 min established patient, moderate complexity): ~$120-130
• CPT 90792 (60-min initial psychiatric evaluation): ~$200-250

These are national average reimbursements from major private insurers. Rates vary by region and payer mix, but telehealth visits using these codes are paid identically to in-person visits when parity laws apply.

For telehealth billing, you’ll typically use:

• Modifier 95 or GT to designate a telehealth service (or Place of Service code 02)
• Same CPT codes as in-person
• Proper documentation that standard of care was met via audio-video

Medicare has been particularly supportive of tele-mental health. Federal legislation extended Medicare telehealth coverage for behavioral health services through 2024, then again through at least September 30, 2025 (with bipartisan support for further extension). Medicare pays the same Physician Fee Schedule rate for telehealth mental health visits as for office visits — roughly $115 for a 99214, $80 for a 99213.

One note for platforms using NPs: Medicare reimburses NPs at 85% of the physician fee schedule when billing under the NP’s NPI. So that same 99214 that pays a psychiatrist $115 would pay an NP ~$98. (This doesn’t apply if billing ‘incident-to’ a physician, but that’s difficult to structure in telehealth.) This 15% differential is a consideration for practice economics but doesn’t change the fact that telehealth pays comparably to in-person.

Medicaid and Commercial Payers

Most state Medicaid programs now cover telehealth for mental health at parity. States like Texas and Illinois reimburse Medicaid tele-psychiatry at the same rate as face-to-face. Florida’s Medicaid program expanded coverage during COVID and has maintained it.

Commercial insurers (Blue Cross, United, Aetna, Cigna, etc.) have universally adopted telehealth for mental health. They recognize that telehealth reduces their costs (fewer ER visits, better medication adherence, improved outcomes) while expanding provider availability in shortage areas. Insurers are paying standard rates.

Cash-pay and membership models are also popular in telepsychiatry. Some platforms charge patients directly ($99-199 for initial visits, $79-99 for follow-ups) and avoid insurance entirely. This eliminates credentialing hassles and ensures consistent revenue, though it limits access for patients without disposable income.

The ROI Reality

Compare the economics:

Traditional practice: You need office space ($2,000-5,000/month), front desk staff ($3,000-4,000/month), malpractice insurance, EHR system, marketing to fill your schedule. Your break-even is probably 15-20 patients/week before you see profit.

Telehealth platform (like Klarity): Zero overhead. The platform handles patient acquisition, scheduling, EHR, billing, compliance. You log in, see patients, get paid per visit. You control your schedule — work 10 hours/week or 40 hours/week.

The per-visit economics are identical (thanks to parity laws), but your cost structure drops to near-zero in telehealth. That’s why platforms like Klarity can offer competitive compensation while handling all the infrastructure headaches.

Controlled Substances and Depression: What You Need to Know

Most depression medication management involves non-controlled substances (SSRIs, SNRIs, bupropion, mirtazapine, TCAs). These can be prescribed via telehealth in all states with zero additional restrictions beyond standard prescribing practices.

But depression often co-occurs with anxiety, insomnia, ADHD, or treatment-resistant cases where you might prescribe:

• Benzodiazepines (Schedule IV) for severe anxiety or panic disorder comorbid with depression
• Stimulants (Schedule II) for comorbid ADHD or depression with severe fatigue/cognitive symptoms
• Sleep medications (Schedule IV like zolpidem) for insomnia

Federal Telehealth Prescribing Rules

Pre-pandemic, the Ryan Haight Act required an in-person medical evaluation before prescribing controlled substances (with limited exceptions). When COVID hit, the DEA waived this requirement to enable telemedicine prescribing of controlled medications during the public health emergency.

As of 2026, these flexibilities remain in effect. The DEA extended the temporary telemedicine prescribing rules through December 31, 2024, then again through the end of 2025. The DEA and HHS are developing permanent telemedicine prescribing regulations, expected by late 2025.

What this means practically: You can legally prescribe Schedule II-V controlled substances via telehealth nationwide under current federal policy, as long as:

• You conduct a proper audio-video evaluation (establishing a legitimate provider-patient relationship)
• You’re licensed in the patient’s state
• You maintain proper documentation and clinical justification
• You follow state-specific requirements (see below)

State-Level Nuances

Some states impose additional rules on controlled substance prescribing:

Texas: Generally allows telehealth prescribing of controlled substances for mental health treatment under the federal waiver. Texas law recognizes that mental health services can establish a patient-physician relationship via telemedicine. NPs, however, face tight restrictions on Schedule II prescribing even in-person.

Florida: Permits telehealth prescribing of controlled substances except for treating chronic non-cancer pain (with exceptions). Mental health treatment is explicitly allowed. Florida requires e-prescribing and PDMP (prescription drug monitoring program) checks for controlled substances.

California, New York, Pennsylvania, Illinois: All allow telehealth controlled substance prescribing under the federal emergency rules, with standard PDMP and documentation requirements.

Practical Guidance for Depression + Anxiety Cases

Let’s say you’re treating a patient with major depressive disorder and comorbid generalized anxiety disorder. You start an SSRI (sertraline 50mg) via telehealth — no issues, it’s not controlled.

Two weeks later, the patient reports worsening panic attacks while the SSRI takes effect. You prescribe lorazepam 0.5mg PRN (Schedule IV benzodiazepine) as a bridge medication. Under current rules:

• Federally legal via telehealth (temporary rule in effect)
• State-legal in all priority states for mental health treatment
• Clinical documentation required: note the panic symptoms, why a benzodiazepine is clinically indicated, plan to taper as SSRI takes effect, safety discussion about dependence risk

You e-prescribe to the patient’s pharmacy. Most platforms have PDMP integration to check for other controlled substance prescriptions (required in many states). Document the consultation, and you’re compliant.

The key is clinical appropriateness. The rules enable telehealth prescribing of controlled substances when medically necessary — they don’t encourage cavalier prescribing. Treating depression sometimes requires these tools, and telehealth doesn’t prevent you from using them.

FAQ: Provider Questions About Telehealth Depression Prescribing

Do I need a separate DEA registration for each state to prescribe controlled substances via telehealth?

No. You need one DEA registration at your primary practice location. That DEA number covers prescribing controlled substances to patients in any state where you’re licensed (assuming federal and state law allows telehealth prescribing). Some states require you to register in their state prescription monitoring program (PDMP) to prescribe controlled substances to their residents, but that’s separate from DEA registration.

Can I prescribe MAOIs via telehealth for treatment-resistant depression?

Yes, if clinically appropriate. MAOIs aren’t controlled substances, so there are no special telehealth restrictions. You’d need to ensure proper patient education about dietary restrictions, conduct appropriate monitoring (blood pressure checks the patient can do at home or at a local clinic), and document thoroughly. Same standard of care as in-person, just delivered remotely.

What about esketamine (Spravato) for treatment-resistant depression?

Esketamine is Schedule III and FDA-approved for treatment-resistant depression, but it requires in-person administration under REMS (Risk Evaluation and Mitigation Strategy) program guidelines. You can’t prescribe esketamine for home use or administer it via telehealth. You can coordinate care — evaluating the patient via telehealth, referring to an in-person clinic for esketamine administration, and managing other medications remotely. Some hybrid models are emerging.

If I’m a PMHNP in a restricted state, can I prescribe via telehealth if my supervising physician is in a different city?

Yes, as long as your collaborative agreement meets state requirements. The supervising physician doesn’t typically need to be physically co-located with you. Most states allow ‘long-distance’ supervision with proper chart review and communication protocols. Check your state’s specific rules — some require periodic face-to-face meetings between NP and supervisor (quarterly or annually), but day-to-day practice can be remote.

Do telehealth parity laws apply to cash-pay patients, or just insurance?

Parity laws govern insurance reimbursement — they ensure insurers pay telehealth visits at the same rate as in-person. If you’re practicing on a cash-pay basis (patient pays you directly, no insurance involved), parity laws don’t directly apply. However, you’re free to set your own fees. Most cash-pay telehealth practices charge $150-250 for initial psychiatric evaluations and $99-149 for medication follow-ups, which is competitive with in-person rates.

Can I prescribe across state lines if I join an interstate compact?

The Interstate Medical Licensure Compact (IMLC) streamlines the process of obtaining licenses in multiple states but doesn’t itself grant prescribing authority. You still need full licensure in each state where you practice. The Compact just makes it easier and faster to get those licenses (often within 30-60 days instead of 6+ months). Once licensed in multiple states via the Compact, yes, you can prescribe to patients in those states via telehealth.

For NPs, there’s a Nurse Licensure Compact (eNLC) that allows multi-state practice with a single license, but it only includes 40 states and has limitations for advanced practice (NPs often still need to apply for APRN recognition in each state). Check whether your states participate.

What happens if federal controlled substance telehealth rules expire and aren’t made permanent?

If the temporary DEA flexibilities sunset without replacement, we’d revert to the Ryan Haight Act requirements: an in-person exam before prescribing controlled substances via telemedicine (with narrow exceptions). This would significantly limit benzodiazepine and stimulant prescribing via telehealth.

However, there’s strong bipartisan pressure to make permanent rules. The DEA proposed regulations in 2023 (with significant provider and patient feedback), and Congress has repeatedly extended temporary rules. Most policy experts expect some form of permanent telehealth controlled substance prescribing will be established — the question is what guardrails will be included. Stay tuned to DEA announcements in late 2025.

For non-controlled depression medications (the vast majority of antidepressants), this is irrelevant — you can prescribe them via telehealth indefinitely under standard state licensing rules.

The Business Case: Why Telehealth Depression Management Makes Sense in 2026

The regulatory and reimbursement landscape has caught up with the clinical reality: telehealth is a fully viable, well-paid, low-overhead way to practice psychiatry.

Consider the market conditions:

Supply shortage: The U.S. faces a severe psychiatrist shortage. Over 122 million people live in federally designated Mental Health Professional Shortage Areas. States like Texas (1 psychiatrist per 9,000 residents) and Florida (1 per 8,500) are severely underserved. Even well-supplied states like New York have shortages in rural areas.

Patient demand: Depression affects 21 million U.S. adults annually. Wait times for psychiatric appointments average 45-60 days in many markets. Patients are actively seeking providers, especially for medication management.

Payment parity: Telehealth visits are reimbursed at the same rates as in-person in most cases — $120-130 for a 30-minute med check from private insurance, $115 from Medicare. No financial penalty for delivering care remotely.

Zero overhead model: Platforms like Klarity Health handle patient acquisition, scheduling, credentialing, billing, compliance, EHR — all the expensive infrastructure of traditional practice. You focus purely on clinical care.

Patient acquisition cost reality: If you tried to build your own practice, you’d face brutal economics. DIY marketing for psychiatric patients costs $200-500+ per acquired patient when you factor in SEO agencies, Google Ads at $15-40/click, staff time to qualify leads, no-shows from cold leads, and the 6-12 months before SEO generates meaningful traffic. Most solo providers don’t have the budget or expertise to compete.

Compare that to a platform model: You pay a standard fee per booked patient (Klarity’s model), and you get pre-qualified patients already matched to your specialty and availability. That’s guaranteed ROI — you only pay when you actually see a patient. No wasted ad spend, no hoping your SEO eventually works, no hiring a marketing agency at $3,000-5,000/month with uncertain results.

For providers, especially those starting out, scaling up, or wanting flexible schedules, telehealth via a platform removes all the risk of traditional practice while maintaining (or exceeding) the income potential.

Bottom Line: You Can Prescribe, You’ll Get Paid, and Patients Need You

Whether you’re a psychiatrist with full independent authority or a PMHNP navigating state-specific scope of practice rules, telehealth depression prescribing is clinically sound, legally clear, and financially viable in 2026.

The regulatory infrastructure is in place. Parity laws ensure fair payment. Patients desperately need access to providers. And platforms like Klarity Health have eliminated the traditional barriers to practice — office overhead, patient acquisition costs, administrative burden.

If you’re licensed (or willing to get licensed in high-demand states), credentialed in your specialty, and ready to treat patients who need you, there’s never been a better time to practice telepsychiatry.

The question isn’t whether you can prescribe depression medications via telehealth — you absolutely can. The question is whether you’re ready to meet the massive unmet need with a practice model that actually works in your favor.

References and Sources

1. California Legislative Information, Assembly Bill No. 890 – NP Independent Practice Authority Law (Passed Sept 29, 2020; Implementation phases 2023-2026). Official California statute establishing pathway for NP independent practice. www.leginfo.legislature.ca.gov

2. Florida Legislative Archive, HB 607 (2020) – Autonomous APRN Practice Act (Effective July 1, 2020). Florida statute creating autonomous practice for primary care NPs (excluding psychiatric NPs). www.flsenate.gov and summary by Florida Association of Nurse Practitioners www.flanp.org

3. American Association of Nurse Practitioners (AANP), State Practice Environment Profiles – Texas, California, New York, Pennsylvania, Illinois, Florida (Data verified 2024-2026). Official AANP classifications of state NP practice authority (Full/Reduced/Restricted). www.aanp.org/advocacy (and state-specific pages)

4. Rivkin Radler LLP Legal Analysis, ‘New Law Allows Experienced NPs to Practice Without Collaborative Agreements in New York’ (Published April 13, 2022). Legal interpretation of NY’s 2022 Nurse Practitioner Modernization Act establishing FPA. www.jdsupra.com

5. Texas Nurse Practitioners Association, ‘News, Laws & Regulations: DEA Extends Telemedicine Prescribing Flexibilities’ (Published Oct 6, 2023). Summary of federal DEA extension of controlled substance telehealth prescribing through Dec 31, 2024. texasnp.org

6. Axios Health Policy, ‘DEA extends COVID-era telehealth prescribing rules through 2025’ (Published Nov 18, 2024). News report on DEA/HHS extension of telemedicine controlled substance prescribing through end of 2025. www.axios.com

7. iCanotes Healthcare IT Blog (Dr. October Boyles), ‘Telehealth Parity Laws: What Mental Health Professionals Need to Know’ (Updated Aug 6, 2025). Analysis of state telehealth parity laws citing AANP/CCHP data: 44 states with coverage mandates, 23 with payment parity. www.icanotes.com

8. PayerPrice Healthcare Cost Database, CPT Code 99214 Reimbursement Rates by Payer (Data verified Feb 2026). Industry database showing average reimbursement for 99214 (psychiatric med management visit): ~$120-130 national average from major commercial insurers. payerprice.com

9. LegalClarity.org, ‘Medicare Nurse Practitioner Coverage and Reimbursement’ (Published Dec 17, 2025). Explanation of Medicare payment policy: NPs reimbursed at 85% of physician fee schedule (42 CFR 414). legalclarity.org

10. Healing Psychiatry Florida, ‘Psychiatrist Shortage by State: 2026 Data and Rankings’ (Published Jan 15, 2026). Compilation of psychiatrist-to-population ratios by state using HPSA data (Texas 1:8,966, Florida 1:8,577, New York 1:2,913, etc.). www.healingpsychiatryflorida.com

All sources accessed and verified February 2026. Regulatory information cross-referenced with official state board sites and recent legislative updates for accuracy.

Source:

• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.aanp.org/advocacy/texas#:~:text=Regulatory%20Structure
• https://www.flanp.org/page/PastNewLaws#:~:text=must%20engage%20in%20such%20practice,is%20composed%20of%209%20members
• https://texasnp.org/news-laws-and-regulations/#:~:text=,or%20before%20November%2011%2C%202023
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,controlled%20substances%20like%20Adderall%20without
• https://www.leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB890#:~:text=education%2C%20experience%2C%20and%20certification%20requirements,The%20bill%20would%20require%20the
• https://www.icanotes.com/2022/03/09/telehealth-parity-laws/#:~:text=reports%20that%2044%20states%2C%20the,or%20limitations%20in%20their%20implementation
• https://payerprice.com/rates/99214-CPT-fee-schedule#:~:text=National%20average%20reimbursement%20for%20CPT,99214%20by%20major%20payers
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=42%20%20,9%2C318
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=43%20%20,9%2C327